An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: Effects of p53 expression [PDF]
, 2003 Rosalyn D. Blumenthal +4 more
openalex +1 more source
Radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma (NHL) with IDEC-Y2B8
, 1998 G. Wiseman +11 more
openalex +1 more source
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma [PDF]
, 2004 Andres Forero +13 more
openalex +1 more source
Improved radioimmunotherapy of hematologic malignancies. Final technical report
, 1996 Oliver W. Press
openalex +2 more sources
Feasibility of Radioimmunotherapy of Experimental Pneumococcal Infection [PDF]
, 2004 Ekaterina Dadachova +7 more
openalex +1 more source
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome [PDF]
, 2004 Apostolia M. Tsimberidou +4 more
openalex +1 more source
186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma [PDF]
, 2004 Stefan Knop +5 more
openalex +1 more source
In vivo Evaluation of 177Lu- and 67/64Cu-Labeled Recombinant Fragments of Antibody chCE7 for Radioimmunotherapy and PET Imaging of L1-CAM-Positive Tumors [PDF]
, 2005 Jürgen Grünberg +8 more
openalex +1 more source
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy.
The Lancet Oncology, 2019 E. Deutsch +3 more
semanticscholar +1 more source